Investment Firm
Overview
IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.
Oct 05, 2021
Oct 05, 2021
Seed
Highlights
Location
Social
Investor Lead
N/A
Participant Investors
6
IpiNovyx Bio raised $10000000 on 2021-10-05 in Seed Round
IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.
Company Funding History
1
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Oct 05, 2021 | Seed Round - IpiNovyx Bio | 8 | - | 10.0M |
Recent Activity
There is no recent news or activity for this profile.